Alnylam Pharmaceuticals
ALNY
#634
Rank
C$44.44 B
Marketcap
$344.56
Share price
-0.80%
Change (1 day)
51.92%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company